main_header@2x

Increase Success in Drug Discovery While Reducing Time and Cost with RepliGut®

ABOUT US

Altis Biosystems has created a next-generation in vitro platform that reduces the time and cost of developing safer, more effective drugs.

By replicating native human biology, the intestinal stem cell platform produces more accurate and reproducible data for better clinical trial performance and reduces the need for animal testing.

home_img1_mob

PLATFORM

The RepliGut® Platform

RepliGut® is a unique, stem cell derived platform that recreates the human small intestine and colonic epithelium for more biologically relevant screening of compounds, disease modeling, and microbiome research.

With a scalable platform, actionable data, high throughput screening to test thousands of compounds, and an unrivaled biobank, RepliGut® is the future of in vitro testing during drug development.

SERVICES

The RepliGut® is a reproducible and scalable platform that is suitable for studying many aspects of drug disposition including toxicity, metabolism, drug absorption, and efficacy.

home_icon1

Intestinal Barrier Function

Maintains barrier integrity with high TEER values

Inflammatory Response

Inflammatory Response

Comprised of polarized intestinal cells grown on transwells

home_icon4

GI Toxicity

Screen compounds for 
drug-induced GI toxicity early

home_icon3

Intestinal Drug Disposition

Developed to replace Caco-2 cells (cancer cells) and animals

NEWS AND ARTICLES

April 1, 2022

The Next Big Thing in Pharma

Bill Thelin, Ph.D, Chief Scientific Officer at Altis Biosystems discusses the future of healthcare, and what's the next big thing in pharma. Bill focuses on how the development of microphysiological systems will support the development of drugs from discovery to humans.    

Watch Video

March 31, 2022

A Human HTS Platform for Assessing Gastrointestinal Toxicity (GIT) Risk in Early Development

There is a significant unmet need for human models of GI risk assessment that can be utilized for drug optimization in early development.

Read More

DIGITAL EVENTS

CONTACT US

Have a question? Want to stay informed about Altis, RepliGut, and more platforms currently under development? Send us a message!